A phase I study of recombinant adenovirus vector-mediated delivery of an anti-erbB-2 single-chain (sFv) antibody gene for previously treated ovarian and extraovarian cancer patients

Ronald D. Alvarez, David T. Curiel

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations
Original languageEnglish
Pages (from-to)229-242
Number of pages14
JournalHuman Gene Therapy
Issue number2
StatePublished - Jan 20 1997

Cite this